Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 351

1.

Intracerebral streptozotocin model of type 3 diabetes: relevance to sporadic Alzheimer's disease.

Lester-Coll N, Rivera EJ, Soscia SJ, Doiron K, Wands JR, de la Monte SM.

J Alzheimers Dis. 2006 Mar;9(1):13-33.

PMID:
16627931
2.

Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease--is this type 3 diabetes?

Steen E, Terry BM, Rivera EJ, Cannon JL, Neely TR, Tavares R, Xu XJ, Wands JR, de la Monte SM.

J Alzheimers Dis. 2005 Feb;7(1):63-80.

PMID:
15750215
3.

Therapeutic rescue of neurodegeneration in experimental type 3 diabetes: relevance to Alzheimer's disease.

de la Monte SM, Tong M, Lester-Coll N, Plater M Jr, Wands JR.

J Alzheimers Dis. 2006 Sep;10(1):89-109. Review.

PMID:
16988486
4.

Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer's disease: link to brain reductions in acetylcholine.

Rivera EJ, Goldin A, Fulmer N, Tavares R, Wands JR, de la Monte SM.

J Alzheimers Dis. 2005 Dec;8(3):247-68.

PMID:
16340083
5.

Limited Alzheimer-type neurodegeneration in experimental obesity and type 2 diabetes mellitus.

Moroz N, Tong M, Longato L, Xu H, de la Monte SM.

J Alzheimers Dis. 2008 Sep;15(1):29-44.

PMID:
18780965
6.
7.
10.

Mechanisms of nitrosamine-mediated neurodegeneration: potential relevance to sporadic Alzheimer's disease.

de la Monte SM, Tong M.

J Alzheimers Dis. 2009;17(4):817-25. doi: 10.3233/JAD-2009-1098.

11.

Cellular distribution of insulin-like growth factor-II/mannose-6-phosphate receptor in normal human brain and its alteration in Alzheimer's disease pathology.

Kar S, Poirier J, Guevara J, Dea D, Hawkes C, Robitaille Y, Quirion R.

Neurobiol Aging. 2006 Feb;27(2):199-210. Epub 2005 Apr 9.

PMID:
16399207
12.

Insulin and insulin-like growth factor resistance with neurodegeneration in an adult chronic ethanol exposure model.

Cohen AC, Tong M, Wands JR, de la Monte SM.

Alcohol Clin Exp Res. 2007 Sep;31(9):1558-73. Epub 2007 Jul 11.

PMID:
17645580
13.

Nitric oxide synthase 3-mediated neurodegeneration after intracerebral gene delivery.

de la Monte SM, Jhaveri A, Maron BA, Wands JR.

J Neuropathol Exp Neurol. 2007 Apr;66(4):272-83.

14.

Alzheimer-like changes in rat models of spontaneous diabetes.

Li ZG, Zhang W, Sima AA.

Diabetes. 2007 Jul;56(7):1817-24. Epub 2007 Apr 24. Erratum in: Diabetes. 2007 Oct;56(10):2650.

15.

Central insulin resistance as a trigger for sporadic Alzheimer-like pathology: an experimental approach.

Salkovic-Petrisic M, Hoyer S.

J Neural Transm Suppl. 2007;(72):217-33. Review.

PMID:
17982898
16.

Alzheimer-like changes in protein kinase B and glycogen synthase kinase-3 in rat frontal cortex and hippocampus after damage to the insulin signalling pathway.

Salkovic-Petrisic M, Tribl F, Schmidt M, Hoyer S, Riederer P.

J Neurochem. 2006 Feb;96(4):1005-15. Epub 2006 Jan 12.

17.

Alzheimer-associated neuronal thread protein mediated cell death is linked to impaired insulin signaling.

de la Monte SM, Wands JR.

J Alzheimers Dis. 2004 Jun;6(3):231-42. Review.

PMID:
15201478
18.

Gene expression alterations in brain areas of intracerebroventricular streptozotocin treated rat.

Gr├╝nblatt E, Koutsilieri E, Hoyer S, Riederer P.

J Alzheimers Dis. 2006 Aug;9(3):261-71.

PMID:
16914836
19.

The relationship between Alzheimer's disease and diabetes: Type 3 diabetes?

Kroner Z.

Altern Med Rev. 2009 Dec;14(4):373-9. Review.

20.

Reduced brain antioxidant capacity in rat models of betacytotoxic-induced experimental sporadic Alzheimer's disease and diabetes mellitus.

Tahirovic I, Sofic E, Sapcanin A, Gavrankapetanovic I, Bach-Rojecky L, Salkovic-Petrisic M, Lackovic Z, Hoyer S, Riederer P.

Neurochem Res. 2007 Oct;32(10):1709-17. Epub 2007 Jun 29.

PMID:
17605105
Items per page

Supplemental Content

Write to the Help Desk